SYNTH-16 · Guide

HR vs VO₂ as marker of HIT aerobic effectiveness

Field-side decision matrix

Blimited evidenceMostly from trained to highly trained athletesWritten before October 2026, being re-checked

The core problem

The aerobic effectiveness of a HIT session is conventionally described by *time spent at a high fraction of VO₂max* (≥90% VO₂max is the usual convention, not an outcome-validated threshold in this base; REF-041 below related the mean %VO₂max of the work intervals, not time ≥90%, to adaptation). REF-041 (n=22 well-trained cyclists, 21 sessions of 5×8 min at 40-min power over 9 weeks, VO₂ measured in every session) found that the %VO₂max sustained during the work intervals predicted the gains: VO₂max (R² adj = 0.54), maximal aerobic power (R² = 0.44), a performance index (R² = 0.36) and power at 4 mmol/L (R² = 0.25).

But VO₂ is not measurable in routine training without a metabolic cart.

Athletes and coaches default to % HRmax + power-time-at-target as field-side surrogates. REF-041 also evaluated the %HRmax surrogate against the same adaptation outcomes — it was related to fewer outcome variables and showed poorer session-to-session repeatability than %VO₂max; the authors conclude %VO₂max is the measure that best reflects the magnitude of adaptation.

A direct within-session demonstration: in REF-194 (11 well-trained cross-country skiers, 5×5 min, abstract-checked 2026-09-27) fast-start intervals produced a higher peak and average VO₂ than constant-speed intervals at the same mean speed (98.2 vs 95.4% and 87.6 vs 86.1% VO₂peak) with a lower RPE — and no difference in mean heart rate.

Same HR, slightly more oxygen uptake (about 1.5 points of VO₂peak on average; one acute session in skiers — a transfer for cyclists and runners).

Why %HRmax under-predicts %VO₂max

Inference from the measured dissociation above; the mechanisms in this table are physiological reasoning (the REF-041 entry carries stroke volume, day-to-day noise and HR plateau as interpretation or inference, not measurement).

Source of dissociationMechanismPractical impact
Stroke volume not measuredQ̇ = HR × SV; wearable sees only HR. Two identical-HR sessions can differ in Q̇ and VO₂Avoid comparing absolute %HRmax across sessions or athletes
HR plateaus / suppresses at very high powerCardiac drift saturates; sympathetic drive can flatten HR while VO₂ climbsIn fast-start formats, HR underestimates true aerobic load of the first hard intervals (REF-194: higher VO₂ at the same mean HR)
HydrationPlasma-volume drop → SV down → HR up at same VO₂Dehydrated session shows higher %HRmax for same true %VO₂max
Ambient temperatureCardiovascular drift; skin-blood-flow stealHot session inflates %HRmax relative to %VO₂max
Caffeine intake↑ HR via β-adrenergicPre-session espresso shifts HR up independent of VO₂
Residual fatigue / sleep debtAltered autonomic balanceHR can be elevated OR suppressed depending on phase of fatigue (early = ↑HR, deep NFOR = ↓HRmax)
Psychological stress / pre-raceSympathetic activationHR overshoots VO₂
β-blockers, certain antihistamines, illnessPharmacological / pathological HR changeInvalidates HR-based comparison entirely until resolved

Field-side decision matrix

Tier 1 (most robust — the tier ranking in this matrix is the base's own practice, not from a study; no entry here tested power-time-at-target against adaptation): Power-based dose. Time at or above a defined %PO40min / %MAP target (e.g. time >90% MAP, time at ≥VO₂max-power). Cycling-specific and unaffected by SV, hydration, T, caffeine. Use as primary intra-session metric.

Caveat: durability-decoupling (REF-423; REF-426 in that range is unverified) means late-session power at the same %FTP costs more — read alongside cumulative duration.

⚠ Tier 1 invalid sub-metric: "work above CP/FTP" in kJ. Although this number is prominently displayed by WKO5, TrainingPeaks, intervals.icu and similar tools, it does NOT track time>90% VO2max or mean %VO2max across HIT formats — they dissociate (REF-130 Vaccari 2020: the abstract reports time >90% VO₂peak of 312 s for decreasing-length intervals vs 182 s for short 30/20 and 179 s for long 3/2 intervals, at similar time to exhaustion, lactate and RPE; the work-above-CP comparison is full-text data carried by the REF-130 entry (not in the abstract; the entry checked it against the full text 2026-09-27): mean %VO₂max 84.2 / 81.5 / 79.6% and work above CP 22.0 / 18.7 / 19.3 kJ for decreasing / short / long — the format with by far the most time >90% VO₂peak had only slightly more work above CP than the long format, and the short format had less work above CP than the long one at the same time >90%).

VO2 during HIT depends on the interaction of work intensity, recovery intensity, and work:rest ratio — not on total work-above-threshold integral (inference).

Short formats keep VO2 elevated during brief recoveries (slow off-kinetics) and accumulate %VO2max minutes despite modest work-above-CP totals (inference, not tested in REF-130 — there the short format did not beat the long one on time >90% VO₂peak). Use time-at-or-above target power, NOT total kJ above CP/FTP, for session-quality evaluation (the kJ dissociation is REF-130's full-text data; time-at-target-power as the replacement is the base's own practice, not from REF-130).

Same logic-class as the %HRmax caveat below — a popular convenience metric that doesn't track the underlying aerobic signal.

Tier 2: %HRmax time-in-zone, interpreted with confounder control. Useful for:

Within-athlete trend across sessions of the same format on a similar day (same hydration, T, caffeine, prior-day TSS, sleep).
Spotting non-aerobic-explained drift: if power-target was hit but %HRmax was unusually low → check accumulated fatigue (suppressed HR) or a cool, well-hydrated day; if unusually high → check dehydration / heat / caffeine / illness (inference, as in the table above).
NOT for comparing fast-start 5×5' vs 30/15 vs constant 5×8' for "which gave more time near VO₂max" — HR did not separate fast-start from constant reps (REF-194: more VO₂ at the same mean HR), and average power does not separate formats either (REF-046: at identical mean power, 30/15 gave 1123 s ≥90% VO₂max vs 879 s continuous and 917 s for 60/60, n=19).Which format gives more time near VO₂max is a lab result to take from those entries, not something to read off either field metric.

Tier 3: Subjective markers — RPE per interval, ability to hit target power on the last work-bout, breathing quality. Cheap, fast, surprisingly informative when combined with Tier 1/2.

Tier 4 (optional, expensive): Direct VO₂. Cosmed K5 or similar portable metabolic systems are emerging in 2026 but remain impractical for routine training. Reserve for lab benchmarking.

Protocol — field-side HIT effectiveness evaluation

Not from a study; the base's own practice (the tiers, the three-number readout, the 4-6 week trend and the 3-5 session rule are house procedure built on the evidence above).

1

Plan the session by power: define target % PO40min / MAP, expected time-at-target. This is the *prescription*.

2

During the session: monitor power vs target (Tier 1). HR is a backup if power data is glitchy.

3

After the session, compute three numbers:

Time at/above power target (Tier 1)
%HRmax-time-in-zone (Tier 2)
RPE of the hardest work-bout (Tier 3)
4

Interpret:

Power target hit + HR in expected range + RPE plausible → session was effective, log and progress.
Power target hit + HR much lower than expected → likely effective but check confounders (fatigue suppressing HR? Cool/well-hydrated session?). Do not down-rate.
Power target hit + HR much higher than expected → check hydration, T, caffeine, sleep. Effectiveness still likely OK, but recovery cost may be higher.
Power target missed → re-evaluate target, fatigue state, or session quality regardless of HR.
5

Across a 4-6 week block: trend the Tier 1 metric. If power-time-at-target is increasing for the same prescribed target → aerobic capacity is growing.

Common mistakes

Treating "%HRmax-time-in-zone" as the gold-standard outcome. It is a Tier 2 metric; let power dose be primary.
Treating "work above CP/FTP" (kJ) as a HIT-effectiveness score. Prominently displayed by WKO5 / TrainingPeaks / intervals.icu but REF-130 Vaccari 2020 (full-text data, see above) shows this metric dissociates from %VO2max and time>90% VO2max across HIT formats. Use time-at-or-above target power instead.
Comparing %HRmax across very different conditions (lab vs hot road, fresh vs fatigued) and concluding one session was "better."
Ignoring HR drift in long fast-start formats — HR can plateau on bout 4-5 while true VO₂ stays high (inference; REF-194 shows equal mean HR with higher VO₂ across a fast-start session). Trust power dose.
Drawing strong conclusions from a single session. Both HR and power-at-target have within-athlete variance (REF-041: %HRmax repeated worse session to session than %VO₂max); trend across 3-5 sessions is more reliable than any single readout.
Reading the wearable "strain" / "recovery" score as a proxy for HIT effectiveness. These are proprietary composites that REF-364 did not validate against performance outcomes; they are not a %VO₂max measure.
How this entry was checked and changed
Why this level

(for the HR-vs-VO₂ and kJ-vs-VO₂ dissociation; the tier ranking and the field protocol are the base's own practice) — regraded 2026-09-27 from B+: its primaries REF-041 (B) and REF-046 (B+) were regraded; the A-range entries it cites are side references, not the core evidence: REF-422 (A-) and, inside the REF-394–406 context range, REF-398 and REF-399 (A-) and REF-403 (A)

Content correction 2026-09-27
"%HRmax did NOT reach statistical significance" -> REF-041's abstract: %HRmax was related to fewer outcome variables and repeated worse session to session. "R² = 0.44 for ΔVO₂max" -> 0.44 is for maximal aerobic power; VO₂max R² = 0.54, performance index 0.36, 4-mmol power 0.25; n=22 added.
Added REF-194's abstract result (higher VO₂ and lower RPE at the same mean speed with no difference in mean HR) as the direct HR-vs-VO₂ dissociation; the REF-194 entry's numeric table is not in the abstract and is flagged.
REF-130 work-above-CP percentages marked as full-text data (abstract carries only time >90%: 312 vs 182 vs 179 s); mechanism table and HR-plateau claim labelled inference.
REF-365 no longer described as a complementary load view (entry regraded to C: no evidence for ACWR); REF-364 composites described as unvalidated rather than "reflecting internal load"; REF-422 described as what it is (mouth-rinse meta, g = 0.12).
Field protocol (4-6 week trend, 3-5 sessions) labelled house practice.
Full-base sync (later 2026-09-27): REF-130 derived percentages (+70% / +10% / +3.3% / −3.2%) -> deleted from that entry as not in the abstract and inconsistent with its own table; replaced by the table's full-text values (84.2/81.5/79.6% VO₂max; 22.0/18.7/19.3 kJ), still labelled full text.
REF-422 "CNS/RPE-mediated" -> the oral-receptor/central route is the authors' proposal and the RPE link is inference; noted it is about mouth rinse, not ingested caffeine.
Level B+ -> B: REF-041 and REF-046 were cited as A-level; they are now B and B+.
Removed a "pending correction" remark: REF-194 has since been corrected against its abstract.
Resync 2026-09-28: Level line "the one A-range entry it cites is REF-422" -> the REF-394–406 range also holds REF-398/399 (A-) and REF-403 (A); all side references, level unchanged.
Resync 2026-09-28: REF-130 work-above-CP values "full-text data, not checked against the abstract" -> the entry now carries them as full text checked 2026-09-27 (still not in the abstract).
2026-10-01: cross-reference repointed from a merged framework to the one that replaced it (SYNTH-01→31, 05→34, 09→70, 12/15→32, 19→26).
Verification 2026-10-01: all REF-041, REF-130, REF-194 and REF-046 numbers in the body match the entries (R² 0.54/0.44/0.36/0.25; 312/182/179 s; 84.2/81.5/79.6%; 22.0/18.7/19.3 kJ; 98.2/95.4 and 87.6/86.1%; 1123/879/917 s). Level-line grades of REF-041, 046, 422, 398, 399, 403 match their head blocks.
Verification 2026-10-01: the framework's evidence is negative (what HR and kJ cannot say). Its positive rule 'judge by power' is practice and is cited as 'SYNTH-16, B' by another framework (KB.md line 947, 'by power, not heart rate') — that B should not be read as evidence for power dose.
Verification 2026-10-01: the kJ-above-CP 'invalid' verdict rests on one n=12 to-exhaustion crossover whose work-above-CP values (18.7-22.0 kJ, SD 9-11 kJ) are full-text data; the SYNTH matches the entry, but the entry's own limitation ('in a fixed-dose session the dissociation may differ') is not carried.
Verification 2026-10-01: unsourced non-prescriptive statements not flagged: 'every interval session in the app is judged by heart rate' (Applicability), 'Cosmed K5 ... emerging in 2026' (Tier 4).